Antibe Therapeutics Inc. (ATE) Fundamentals
Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The company's pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Antibe's lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids for post-operative pain. Antibe's second pipeline drug, ATB-352, is being developed for a specialized acute pain indication. The company's anticipated next target is inflammatory bowel disease, a condition long in need of safer, more effective therapies.
SHARE INFORMATION
Market Cap$ 29.720.401
Shares Outstanding52.468.809
Float-
Percent Float0,0%
Short Interest31.100,00
Short Percent Float100,0%
Short Interest Ratio0,419477
Short Interest Date2023-01-15
Latest Fiscal Dividend Per Share$ 0,00
Latest Fiscal Revenue$ 2.727.000
Latest Fiscal EPS$ -0,50
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0,00
Dividend (5 Years)$ 0,00
Ex Dividend Date-
Dividend Rate$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions1
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0,0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned57.487.498
TRADING INFO
52 Week High$ 0,83
52 Week Low$ 0,41
52 Week High Change$ -13,64
21 Day Moving Average$ 0,588333
21 Day Extended Moving Average$ 0,583068
50 Day Moving Average$ 0,5278
50 Day Extended Moving Average$ 0,556442
200 Day Moving Average$ 0,602025
200 Day Extended Moving Average$ 0,687835
10 Day Average Volume21.103
20 Day Average Volume27.221
30 Day Average Volume33.070
50 Day Average Volume31.026
Alpha0.005184
Beta-0.136519
Standard Deviation0.21393
R20.000816
7 Day Price Change$ -0,02
7 Day Percent Change-3,39%
21 Day Price Change$ 0,00
21 Day Percent Change0,0%
30 Day Price Change$ 0,12
30 Day Percent Change26,67%
Month to Date Price Change$ 0,10
Month to Date Percent Change21,28%
Quarter to Date Price Change$ 0,10
Quarter to Date Percent Change21,28%
180 Day Price Change$ -0,03
180 Day Percent Change-5,0%
200 Day Price Change$ -0,03
200 Day Percent Change-5,0%
Year to Date Price Change$ 0,10
Year to Date Percent Change21,28%

Antibe Therapeutics Inc. (ATE) Key Ratios

PROFITABILITY
EBIT Margin-271,0%
EBITDA Margin-267,9%
Pre-Tax Profit Margin-110,6%
Profit Margin Count0,0%
Gross Margin62,2%
Profit Margin TOT0,0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0,00
Revenue (3 Years)$ 0,00
Revenue (5 Years)$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,48
Total Debt To Equity0,00
Int Coverage-2.793,10
Current Ratio10,80
Leverage Ratio1,70
Quick Ratio9,60
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-1,40
Enterprise Value$ -24.565.189
Price to Sales0,00
Price to Free Cash-2,30
PE High Last 5 Years-7,90
Price To Book0,65
Price To Cash Flow5,30
PE Low Last 5 Years-4,70
Price to Tangible Book1,48
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover1,40
Assets Turnover0,00
Return Assets-27,41
Return on Equity-46,39
Return on Capital-47,95

Antibe Therapeutics Inc. (ATE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEODaniel Legault
Emplyoees26
Last AuditUE
CIK0001583682
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address15 Prince Arthur Avenue
Toronto, ON M5R 1B2
Websitehttps://www.antibethera.com
Facsimile-
Telephone+1 905 570-5103
Email-
Seu Histórico Recente
TSX
ATE
Antibe The..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20230127 13:44:25